Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLECA-ED: flecainide versus amiodarone for emergency department cardioversion of paroxysmal atrial fibrillation in patients with coronary artery disease
2022-002589-34Phase 3Active
- Sponsor
- Win Medica
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Atrial fibrillation (AFib) comparing Flecainide arm with Amiodarone arm (2 arms). Primary endpoint: Successful conversion to sinus rhythm. Started Oct 2022; status: active.
02
Drugs
flecainideamiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2022-002589-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-002589-34.